1.08
1.08 (0%)
As of Feb 14, 2025
Akari Therapeutics Plc [AKTX]
Source:
Company Overview
Akari Therapeutics Plc is a clinical-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases involving the complement component 5 (“C5”) and leukotriene B4 (“LTB4”) pathways.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (646) 350-0702 |
| Industry | manufacturing |
| CEO | Rachelle Jacques |
| Website | akaritx.com |